You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
尚榮醫療(002551.SZ):2022年度預虧3.8億元-4.8億元 同比盈轉虧

格隆匯1月20日丨尚榮醫療(002551.SZ)公佈2022年度業績預吿,報吿期歸屬於上市公司股東的淨利潤虧損3.8億元-4.8億元,同比盈轉虧;扣除非經常性損益後的淨利潤虧損3.81億元-4.81億元;基本每股收益虧損0.45元/股—0.57元/股。

報吿期內,公司控股子公司合肥普爾德醫療用品有限公司(簡稱“普爾德醫療”)和普爾德控股有限公司(以下簡稱“普爾德控股”)的主要產品為一次性醫用防護產品和一次性醫用耗材產品。受疫情影響,普爾德醫療國內部分工廠和國外工廠停工,影響了訂單的排產;另一方面,上半年受普爾德醫療產品的主要進出口港封港及國際運輸集裝箱緊張的嚴重影響,產品出貨困難,運輸成本居高不下;同時,國內防護產品的供應量趨於平衡,防護產品的毛利率進一步下降,致使報吿期普爾德醫療和普爾德控股的銷售和利潤大幅下降。

根據《企業會計準則第8號-資產減值》及相關會計政策規定,結合公司的實際經營情況及截止報吿期末公司各項資產的運行與財務狀況,基於謹慎性原則,公司對報吿期內出現減值(跌價)跡象的相關資產進行初步減值測試,預計需計提資產減值、信用減值準備合計約38326.88萬元(最終數據以審計報吿為準,以下同解)。報吿期公司對未決訴訟或仲裁事項進行了逐項清理,對有可能形成損失的項目擬計提預計負債6773.99萬元。

此外,由於疫情的持續不利影響,公司醫療專業工程項目的實施進度普遍延長,人工成本及管理成本增加,導致報吿期工程服務業務的毛利率出現較大的下滑。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account